Lifecore Biomedical, Inc. LFCR Reportable Segment — Depreciation
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s reportable segment — depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s reportable segment — depreciation?
- Lifecore Biomedical, Inc. (LFCR) reported reportable segment — depreciation of $2.31M in Q1 2026.
- What does reportable segment — depreciation mean?
- This metric represents the systematic allocation of the cost of tangible assets used by the segment over their useful lives. It provides insight into the capital intensity of the segment's manufacturing infrastructure and the ongoing investment required to maintain production capabilities.